These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20503478)

  • 1. Disease-modifying drug fails in Alzheimer's study.
    Harv Ment Health Lett; 2010 Apr; 26(10):7. PubMed ID: 20503478
    [No Abstract]   [Full Text] [Related]  

  • 2. What can be inferred from the interruption of the semagacestat trial for treatment of Alzheimer's disease?
    Cummings J
    Biol Psychiatry; 2010 Nov; 68(10):876-8. PubMed ID: 21035622
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeting nascent soluble Aβ42 for potential Alzheimer drug development.
    Zhang M; Hausmann L; Song W
    J Neurochem; 2013 May; 125(3):329-31. PubMed ID: 23405973
    [No Abstract]   [Full Text] [Related]  

  • 4. Does rivastigmine improve cognitive functions or disability in patients with Alzheimer's disease?
    Cantisani TA; Celani MG; Righetti E
    Neuroepidemiology; 2004; 23(4):209-10. PubMed ID: 15272224
    [No Abstract]   [Full Text] [Related]  

  • 5. [The pharmacotherapy of the cognitive disorders in Alzheimer's disease. Guidelines for rational drug use--a review].
    Strnad J; Bahro M
    Dtsch Med Wochenschr; 2000 Jul; 125(27):835-9. PubMed ID: 10929539
    [No Abstract]   [Full Text] [Related]  

  • 6. Why did tarenflurbil fail in Alzheimer's disease?
    Imbimbo BP
    J Alzheimers Dis; 2009; 17(4):757-60. PubMed ID: 19542625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendrimeric Poly(Epsilon-Lysine) Delivery Systems for the Enhanced Permeability of Flurbiprofen across the Blood-Brain Barrier in Alzheimer's Disease.
    Al-Azzawi S; Masheta D; Guildford AL; Phillips G; Santin M
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30340406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gamma-secretase inhibitors and modulators].
    Iwai A
    Nihon Rinsho; 2011 Dec; 69 Suppl 10 Pt 2():83-7. PubMed ID: 22755160
    [No Abstract]   [Full Text] [Related]  

  • 9. Galantamine for Alzheimer's disease and mild cognitive impairment.
    Cusi C; Cantisani TA; Celani MG; Incorvaia B; Righetti E; Candelise L;
    Neuroepidemiology; 2007; 28(2):116-7. PubMed ID: 17409773
    [No Abstract]   [Full Text] [Related]  

  • 10. γ-Secretase modulators as potential disease modifying anti-Alzheimer's drugs.
    Oehlrich D; Berthelot DJ; Gijsen HJ
    J Med Chem; 2011 Feb; 54(3):669-98. PubMed ID: 21141968
    [No Abstract]   [Full Text] [Related]  

  • 11. Deal watch: Lilly buys back into the BACE race for Alzheimer's disease.
    Cully M
    Nat Rev Drug Discov; 2014 Nov; 13(11):804. PubMed ID: 25323931
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current and future medical treatment of Alzheimer's disease].
    Lemper JC
    Rev Med Brux; 2005 Sep; 26(4):S294-9. PubMed ID: 16240877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble Aβ42 without affecting other Aβ pools.
    Mitani Y; Yarimizu J; Akashiba H; Shitaka Y; Ni K; Matsuoka N
    J Neurochem; 2013 May; 125(3):465-72. PubMed ID: 23240999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antihypertensive therapy on cognitive decline in Alzheimer's disease.
    Duron E; Rigaud AS; Dubail D; Mehrabian S; Latour F; Seux ML; Hanon O
    Am J Hypertens; 2009 Sep; 22(9):1020-4. PubMed ID: 19590498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the tangled brain of Alzheimer's.
    Wolfson W
    Chem Biol; 2008 Feb; 15(2):89-90. PubMed ID: 18291309
    [No Abstract]   [Full Text] [Related]  

  • 16. Lessons from a failed γ-secretase Alzheimer trial.
    De Strooper B
    Cell; 2014 Nov; 159(4):721-6. PubMed ID: 25417150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Challenging pharmacotherapy in dementia].
    Ihl R
    MMW Fortschr Med; 2009 Mar; 151(13):46-8. PubMed ID: 19504818
    [No Abstract]   [Full Text] [Related]  

  • 18. Donepezil (Aricept) for treatment of Alzheimer's disease and other dementing conditions.
    Geldmacher DS
    Expert Rev Neurother; 2004 Jan; 4(1):5-16. PubMed ID: 15853610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
    Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
    Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alzheimer's disease: therapeutic perspectives].
    Dubois B; De Souza L; Allali G; Kalafat M; Sarazin M
    Bull Acad Natl Med; 2008 Feb; 192(2):333-42; discussion 343-4. PubMed ID: 18819687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.